Tag: Relatlimab

Relatlimab and nivolumab provide greater survival benefit for advanced melanoma

byDavid Xiangand1 others

January 17, 2022

1. In patients with untreated metastatic or unresectable melanoma, the combination of Relatlimab and Nivolumab was associated with greater progression-free ...

2 Minute Medicine® is an award winning, physician-run, expert medical media company. Our content is curated, written and edited by practicing health professionals who have clinical and scientific expertise in their field of reporting. Our editorial management team is comprised of highly-trained MD physicians. Join numerous brands, companies, and hospitals who trust our licensed content.

Recent Reports

SGLT2 inhibitors may delay cognitive impairment in elderly patients with heart failure
Nerandomilast slows decline in FVC in idiopathic pulmonary fibrosis
Mazdutide significantly reduces weight in adults with overweight or obesity

No Result

View All Result